abstract |
The present invention relates to novel 4-pyrazine-2-ylmethyl-morpholines of general formula A, methods for their preparation, pharmaceutical compositions containing them, and therapeutically particularly NR2B negative allosteric regulatory properties. Regarding their use in the treatment or prevention of conditions. TIFF2022505080000141.tif5363A |